These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 23055187
1. Evaluation of retrobulbar blood flow by color doppler ultrasonography after intravitreal ranibizumab injection in patients with neovascular age-related macular degeneration. Sakalar YB, Senturk S, Yildirim M, Keklikci U, Alakus MF, Unlu K. J Clin Ultrasound; 2013 Jan; 41(1):32-7. PubMed ID: 23055187 [Abstract] [Full Text] [Related]
2. Does ranibizumab (Lucentis®) change retrobulbar blood flow in patients with neovascular age-related macular degeneration? Mete A, Saygili O, Mete A, Gungor K, Bayram M, Bekir N. Ophthalmic Res; 2012 Jan; 47(3):141-5. PubMed ID: 22042133 [Abstract] [Full Text] [Related]
3. Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration. Hosseini H, Lotfi M, Esfahani MH, Nassiri N, Khalili MR, Razeghinejad MR, Nouri-Mahdavi K. Retina; 2012 May; 32(5):967-71. PubMed ID: 22146127 [Abstract] [Full Text] [Related]
4. Can intravitreal ranibizumab alter retrobulbar circulation in eyes with age-related macular degeneration? Yuksel K, Altinkaynak H, Kina A, Kara N, Yazici AT, Demirok A. J Ocul Pharmacol Ther; 2013 Oct; 29(8):723-7. PubMed ID: 23829173 [Abstract] [Full Text] [Related]
6. Short-term effects of intravitreal bevacizumab (Avastin(®)) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration. Toklu Y, Cakmak HB, Raza S, Anayol A, Asik E, Simşek S. Acta Ophthalmol; 2011 Feb; 89(1):e41-5. PubMed ID: 21232081 [Abstract] [Full Text] [Related]
7. Effect of intravitreal aflibercept (Eylea®) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration. Gok M, Kapti HB. Int Ophthalmol; 2018 Apr; 38(2):713-719. PubMed ID: 28421399 [Abstract] [Full Text] [Related]
8. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration. Ciulla TA, Harris A, Chung HS, Danis RP, Kagemann L, McNulty L, Pratt LM, Martin BJ. Am J Ophthalmol; 1999 Jul; 128(1):75-80. PubMed ID: 10482097 [Abstract] [Full Text] [Related]
9. Ultrasound assessment of ocular vascular effects of repeated intravitreal injections of ranibizumab for wet age-related macular degeneration. Bonnin P, Pournaras JA, Makowiecka K, Krivosic V, Kedra AW, Le Gargasson JF, Gaudric A, Levy BI, Cohen YS, Tadayoni R, Massin P. Acta Ophthalmol; 2014 Aug; 92(5):e382-7. PubMed ID: 25043792 [Abstract] [Full Text] [Related]
10. Evaluating the Effect of Intravitreal Ranibizumab on Retrobulbar Hemodynamics by Color Doppler Ultrasonography in Neovascular AMD. Raza S, Ergun SB, Toklu Y, Cakmak HB, Ipek A, Cagil N. Ophthalmic Surg Lasers Imaging Retina; 2019 Jul 01; 50(7):437-443. PubMed ID: 31344243 [Abstract] [Full Text] [Related]
11. The effect of photodynamic therapy on retrobulbar blood flow parameters. Türkçüoğlu P, Deniz N, Koç M, Kurt J, Celiker U. Clin Exp Ophthalmol; 2008 Jul 01; 36(1):39-42. PubMed ID: 18190598 [Abstract] [Full Text] [Related]
12. Color Doppler imaging of ocular blood flow after combined photodynamic therapy with intravitreal triamcinolone in age-related macular degeneration. Cekiç O, Bardak Y, Yeşildağ A. Curr Eye Res; 2011 Feb 01; 36(2):149-53. PubMed ID: 21158585 [Abstract] [Full Text] [Related]